SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Blade Therapeutics, Inc. (Blade or the Company), a biopharmaceutical company focused on developing cutting-edge treatments for fibrotic and ...
Use of colorectal cancer subtypes identified through iterative clustering to predict response to therapy. Background: The mammalian target of rapamycin (mTOR) regulates cell growth by integrating ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company focused on developing cutting-edge treatments for debilitating fibrotic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback